XML 189 R79.htm IDEA: XBRL DOCUMENT v3.21.2

Share Based Payment (Tables)

12 Months Ended

Mar. 31, 2021

Disclosure of terms and conditions of share-based payment arrangement [Line Items]

Summary of Number and Weighted Average Exercise Price of Share Options

The number and weighted average exercise price of share options under MMT ESOP plan are as follows:

		Weighted Average Exercise Price per share (USD)				Number of Options				Weighted Average Exercise Price per share (USD)				Number of Options				Weighted Average Exercise Price per share (USD)				Number of Options
		For the Year Ended March 31
Particulars		2019				2019				2020				2020				2021				2021
Outstanding at beginning of the year			1.28				261,410				1.98				17,839				1.98				17,839
Exercised during the year			1.23				(243,571	)			—				—				—				—
Outstanding at the end of the year			1.98				17,839				1.98				17,839				1.98				17,839
Exercisable at the end of the year			1.98				17,839				1.98				17,839				1.98				17,839

Summary of Measurement Used to Determine Fair Values of ESOPs

Inputs for Measurement of Grant Date Fair Values of ESOPs

		For the Year Ended March 31
Fair value of ESOP and assumptions		2020
Share price at grant date (USD)			2,302
Fair value at grant date (USD)		722 - 1,014
Exercise price (USD)			2,229
Expected volatility		43.8% - 49.0%
Expected term		3-5 years
Expected dividends			—
Risk-free interest rate			1.5	%

Summary of Number and Weighted Average Exercise Price of Employee Stock Options under Bona Vita ESOP

The number and weighted average exercise price of employee stock options under the Bona Vita ESOP Plan are as follows:

		Weighted Average Exercise Price per share (USD)				Number of Awards				Weighted Average Exercise Price per share (USD)				Number of Awards
		For the Year Ended March 31
Particulars		2019				2019				2020				2020
Outstanding at beginning of the year			0.0154				21,955				0.0154				13,664
Granted during the year			—				—				—				—
Forfeited and expired during the year			0.0154				(8,291	)			0.0141				(9,117	)
Exercised during the year			—				—				0.0141				(4,547	)
Outstanding at the end of the year			0.0154				13,664				—				—
Exercisable at the end of the year			0.0154				13,664				—				—

Restricted Stock Units [Member]

Disclosure of terms and conditions of share-based payment arrangement [Line Items]

Summary of Terms and Conditions Relating to Grants under Share Incentive Plan

The terms and conditions relating to the RSUs grants under this Share Incentive Plan are given below:

Grant details		Number of instruments				Vesting conditions		Contractual life of RSUs
RSUs granted during the year ended March 31, 2019			1,325,531			Refer notes		4 – 8 years
RSUs granted during the year ended March 31, 2020			1,334,759			Refer notes		4 – 8 years
RSUs granted during the year ended March 31, 2021			1,478,191			Refer notes		4 – 8 years

Summary of Number and Weighted Average Exercise Price under Share Incentive Plan

The number and weighted average exercise price of RSUs under the share incentive plan are as follows:

		Weighted Average Exercise Price per share (USD)				Number of Awards				Weighted Average Exercise Price per share (USD)				Number of Awards				Weighted Average Exercise Price per share (USD)				Number of Awards
		For the Year Ended March 31
Particulars		2019				2019				2020				2020				2021				2021
Outstanding at beginning of the year			0.0005				5,433,399				0.0005				5,734,826				0.0005				6,437,422
Granted during the year			0.0005				1,325,531				0.0005				1,334,759				0.0005				1,478,191
Forfeited and expired during the year			0.0005				(307,257	)			0.0005				(319,399	)			0.0005				(470,810	)
Exercised during the year			0.0005				(716,847	)			0.0005				(312,764	)			0.0005				(1,465,072	)
Outstanding at the end of the year			0.0005				5,734,826				0.0005				6,437,422				0.0005				5,979,731
Exercisable at the end of the year			0.0005				1,650,767				0.0005				2,812,252				0.0005				3,328,012

Employee Stock Options [Member]

Disclosure of terms and conditions of share-based payment arrangement [Line Items]

Summary of Terms and Conditions Relating to Grants under Share Incentive Plan

The terms and conditions relating to the ESOPs grants under this Share Incentive Plan are given below:

Grant details		Number of instruments				Vesting conditions		Contractual life of ESOPs
ESOPs granted during the year ended March 31, 2020			21,588			Refer notes		4 – 7 years

Summary of Number and Weighted Average Exercise Price under Share Incentive Plan

The number and weighted average exercise price of ESOPs under share incentive plan are as follows:

		Weighted Average Exercise Price per ESOP (USD)				Number of Awards				Weighted Average Exercise Price per ESOP (USD)				Number of Awards
		For the Year Ended March 31
Particulars		2020				2020				2021				2021
Outstanding at beginning of the year			—				—				2,229				21,588
Granted during the year			2,229				21,588				—				—
Forfeited and expired during the year			2,229				—				2,229				(1,968	)
Exercised during the year			2,229				—				2,229				(131	)
Outstanding at the end of the year			2,229				21,588				2,229				19,489
Exercisable at the end of the year			—				—				2,229				6,409

X

- Definition

The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 47
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_ComponentsOfEquityAxis=mmyt_RestrictedStockUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ComponentsOfEquityAxis=mmyt_EmployeeStockOptionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: